Neratinib Completed Phase 1 Trials for Malignant Carcinoma / Neoplasms Treatment

Back to Neratinib
IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors